Resmetirom reduces liver fat and improves quality of life of NASH patients Jacinthlyn Sylvia15 Jun 2022 2:30 PM GMTUSA: A new article published in Clinical Gastroenterology and Hepatology shows that in nonalcoholic steatohepatitis (NASH) patients taking resmetirom,...
ADA releases standard of medical care in 2022, here are the important details Dr. Nandita Mohan23 Dec 2021 12:21 PM GMTBased upon the latest scientific diabetes research and clinical trials, the Standards of Care is the gold-standard for professionals in the medical...
Metformin independently reduces mortality in patients with cirrhosis and diabetes: Study Dr. Shravani Dali9 Nov 2021 3:30 AM GMTMetformin exposure in patients with cirrhosis and diabetes appears to be safe and is independently associated with reduced overall, but not...
Lanifibranor reduces lipid, inflammatory, and fibrosis biomarkers in NASH: NEJM MD Editorial Team1 Nov 2021 3:30 AM GMTNonalcoholic steatohepatitis (NASH) management is a situation which still needs to be answered. Lanifibranor is a pan-PPAR (peroxisome...
Semaglutide Resolves Nonalcoholic steatohepatitis, Finds Study Dr Kartikeya Kohli3 April 2021 6:30 AM GMTNonalcoholic steatohepatitis (NASH) is a common disease that is associated with increased morbidity and mortality, but treatment options are limited....
CT may identify patients with high-risk nonalcoholic fatty liver disease Hina Zahid1 Feb 2021 1:45 PM GMTLeesburg, VA, - According to ARRS' American Journal of Roentgenology(AJR), Fibrosis-4 (FIB-4) and multiple CT findings can identify patients with...
Statins use may reduce risk of NAFLD and liver cirrhosis: AJG Study MD Bureau13 Jan 2021 5:31 AM GMTNonalcoholic fatty liver disease (NAFLD) is among the most common causes of chronic liver disease worldwide, and a subset of patients with NAFLD...
Pioglitazione and bariatric surgery best for NASH treatment: Study Medha Baranwal4 Jan 2021 3:22 PM GMTItaly: Weight loss and hepatic insulin improvement are promising approaches for the treatment of Non‐Alcoholic Steato‐Hepatitis (NASH), suggests a...
Stevia extract may reduce biomarkers of fatty liver disease Dr. Kamal Kant Kohli7 May 2020 12:45 PM GMTNon-caloric sweeteners (NCS) are food additives providing sweetness without calories and are considered safe and/or not metabolized by the liver. The...
